Phase II study of nedaplatin plus irinotecan for stage III/IV squamous cell lung cancer (TORG0910)

Trial Profile

Phase II study of nedaplatin plus irinotecan for stage III/IV squamous cell lung cancer (TORG0910)

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Dec 2015

At a glance

  • Drugs Irinotecan (Primary) ; Nedaplatin (Primary)
  • Indications Lung cancer; Squamous cell cancer
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 16 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top